USPTO serial 85606345
NANOTAINER
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- JOINER, KATINA JACKSON
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NANOTAINER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sally M. Abel,
SALLY M ABEL FENWICK & WEST LLP801 CALIFORNIA STMOUNTAIN VIEW, CA 94041-1990UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use; chemical preparations for scientific purposes; reagents for chemical analysis; testing kits containing reagents used in analyzing and detecting certain toxins for clinical or medical laboratory use; genetic identity tests comprised of reagents; antibodies for in vitro scientific or research use; biochemicals for in vitro and in vivo scientific or research use; biomedical compounds for in vitro and in vivo scientific or research use; chemical preparations to be used in biochemical and clinical research; diagnostic preparations for clinical or medical laboratory use | ACTIVE | — |
| 005 | Reagents and media for medical or veterinary purposes; clinical medical reagents; biological and chemical preparations, namely, antibodies for clinical, medical or veterinary use to detect and analyze substances; diagnostic kits for medical or veterinary use comprised of medical diagnostic reagents and assays; diagnostic preparations for medical or veterinary purposes; drug testing kits comprised of medical diagnostic reagents and assays for testing bodily fluids; medical diagnostic test kits comprised of reagents and assays for testing of body fluids; medical diagnostic and monitoring test strips for use in the treatment of a wide variety of diseases and health disorders; test strips for medical and laboratory analysis of blood; ovulation test kits; biological tissue cultures for medical or veterinary purposes; culture media for cultivating blood cells | ACTIVE | — |
| 009 | Computer software for healthcare, namely, computer software for prescribing medication, computer software for ordering medication and/or prescription fulfillment, computer software for drug delivery, computer software for controlling a drug delivery device, computer software allowing a patient to track individual health progress, computer software for ordering laboratory tests, computer software for reporting laboratory test results, computer software for laboratory appointment scheduling and/or check-in, computer software for providing medical billing and/or payment information, computer software for communication and data transfer to health care professionals and/or patients and computer software for medical and/or laboratory data management; computer software for medical monitoring and analysis of medical data; computer software for analysis of body fluids; computer software for communication and data transfer between health care professionals and patients; computer hardware; mobile electronic devices, namely, tablet computers, mobile phones, personal digital assistants, and other cellular or wireless communication devices; downloadable, shared or remotely-viewed electronic publications in the nature of blogs, e-zines, magazines, books, manuals, pamphlets, diaries and journals in the fields of healthcare, medicine, diagnostics and personal health and fitness | ACTIVE | — |
| 010 | Medical devices for laboratory analysis of body fluids and tissue; medical devices, namely, point of care and handheld devices for analysis of drugs, proteins and other substances, and wireless transfer of medical data; medical measuring apparatus, namely, equipment for medical monitoring and analysis of body fluids and tissue; medical measuring apparatus, namely, cartridges for use with therapies or equipment for medical monitoring and analysis of substances; apparatus for blood analysis; apparatus for taking blood samples; blood testing apparatus; apparatus for clinical diagnosis; capillary reagent tubes; capillary tubes for blood; capillary tubes for samples; containers especially made for processing blood samples; containers for medical waste; devices for monitoring blood sugar; diagnostic apparatus for the detection of a wide variety of diseases; health monitoring devices, namely, personal medical monitors for monitoring a wide variety of physical conditions and diseases; medical diagnostics apparatus for diagnosing a wide variety of physical conditions and diseases; medical apparatus and instruments for monitoring blood properties; medical devices for obtaining body fluid samples; patient medical monitors for monitoring a wide variety of physical conditions and diseases; all of the foregoing for use in connection with Trademark Proprietor's medical, laboratory, and/or diagnostic services | ACTIVE | — |
| 035 | Administering pharmacy reimbursement programs and services; administration of patient reimbursement programs; billing; compiling of information into computer databases; management and compilation of computerized databases; medical referrals; physician referrals; medical billing support services; providing an internet-based database of patient medical information designed to facilitate HIPAA-compliant sharing and maintenance of patient medical information between and amongst the patient and healthcare professionals providing services to the patient | ACTIVE | — |
| 036 | Insurance claims processing; pharmaceutical benefit management services; pharmacy benefit management services; medical laboratory benefit management services | ACTIVE | — |
| 039 | Biomedical services, namely, storage of medical data; biomedical services, namely, the storage of human cells for medical use; consulting services in the field of air medical operations in the nature of air medical transport; medical transport services; transportation of medical waste and special waste | ACTIVE | — |
| 042 | Medical and scientific research services in the fields of blood analysis health care and health care monitoring; pharmaceutical research services; pharmaceutical research and development; blood analysis services; chemical laboratories; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; genetic testing of laboratory animals for research purposes; biological research; biomedical research; laboratory research in the field of chemistry, biochemistry, biology, health and medicine; laboratory services, namely, pigment and color analysis; laboratory services, namely, imaging core lab services; medical laboratories; medical laboratory services; providing laboratory research services in the field of gene expression, namely, cancer biology; rental of laboratory apparatus and instruments; scientific laboratory services; providing a web site featuring technology that enables patients, physicians and other healthcare providers to generate, manage and exchange medical information | ACTIVE | — |
| 044 | Medical evaluation services, namely, identifying, quantifying or monitoring a wide variety of physical conditions, traits and diseases; medical evaluation services, namely, assessment of patients undergoing medical treatment; medical monitoring services; medical monitoring services, namely, monitoring the efficacy of therapy and total patient or consumer health; medical diagnostic testing, monitoring and reporting services; collection and preservation of human and animal blood; consulting services in the field of health; consulting services in the field of diagnostic medical testing; consulting services in the fields of health and healthcare; drug use testing services; drug, alcohol and DNA screening for medical purposes; health assessment services, namely, health and fitness evaluations; health care; maintaining patient medical records and files; medical counseling; medical information; medical screening; medical services; medical testing for diagnostic or treatment purposes; providing information in the field of pet health; pet hospital services; providing a web site featuring medical information; providing a website featuring health and healthcare information; internet-based health care information services; providing health information; providing healthcare information; rental of medical equipment; veterinary special services, namely, medical diagnostic and health management services for animals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Theranos, Inc.
- Other trademarks owned by Theranos, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 039
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named NANOTAINER
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 10, 2018 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 10, 2018 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 12, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 10, 2018 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jan 10, 2018 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jan 10, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 11, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 7, 2017 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 7, 2017 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 7, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 27, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 25, 2017 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 25, 2017 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 25, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 9, 2016 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 30, 2016 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Jun 30, 2016 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Jun 30, 2016 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Jan 6, 2015 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 6, 2015 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 5, 2014 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Dec 2, 2013 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Nov 5, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 5, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 16, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 28, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 27, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 26, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 26, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 20, 2013 | ALIE | ASSIGNED TO LIE | — |
| Sep 19, 2013 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 2, 2013 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| May 2, 2013 | GNSF | SUBSEQUENT FINAL EMAILED | — |
| May 2, 2013 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| Mar 11, 2013 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Mar 11, 2013 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 11, 2013 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 15, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 14, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 14, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 24, 2012 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 24, 2012 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 14, 2012 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 14, 2012 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 14, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 10, 2012 | DOCK | ASSIGNED TO EXAMINER | — |
| May 2, 2012 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| May 1, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 27, 2012 | NWAP | NEW APPLICATION ENTERED | — |